文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

院外心脏骤停复苏中一氧化氮供体亚硝酸钠对入院生存率的影响:一项随机临床试验

Effect of Out-of-Hospital Sodium Nitrite on Survival to Hospital Admission After Cardiac Arrest: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2021-01-01

该双盲安慰剂对照2期随机临床试验纳入1502例院外心脏骤停成人,比较院前急救人员给予45 mg或60 mg亚硝酸钠与安慰剂的疗效。主要终点为入院生存率,结果显示亚硝酸钠组与安慰剂组无显著差异,不支持院外心脏骤停复苏中使用亚硝酸钠。

要点

  • 院外心脏骤停患者给予亚硝酸钠未显著改善入院生存率。
  • 45 mg和60 mg亚硝酸钠组入院生存率分别为41%和43%,安慰剂组为44%。
  • 亚硝酸钠组与安慰剂组在出院生存率等7项次要终点上均无显著差异。

核心结论

  • 在院外心脏骤停患者中,与安慰剂相比,给予亚硝酸钠未能显著改善入院生存率。
  • 这些发现不支持在院外心脏骤停复苏中使用亚硝酸钠。

研究设计与样本

  • 双盲、安慰剂对照、2期随机临床试验,纳入1502例华盛顿州King County的院外心脏骤停成人患者。
  • 患者按1:1:1随机接受45 mg亚硝酸钠(n=500)、60 mg亚硝酸钠(n=498)或安慰剂(n=499),由急救人员在积极复苏期间尽早静脉推注。
  • 主要终点为入院生存率,采用单侧假设检验;次要终点包括院外变量和院内变量。

主要发现

  • 45 mg亚硝酸钠组205例(41%)、60 mg组212例(43%)和安慰剂组218例(44%)存活至入院。
  • 出院生存率:45 mg组66例(13.2%)、60 mg组72例(14.5%)、安慰剂组74例(14.9%),均无显著差异。
  • 7项预设次要终点均无显著差异。

关键数值与推荐

  • 主要终点入院生存率:45 mg组41%,60 mg组43%,安慰剂组44%。

临床怎么用

  • 院外心脏骤停复苏中不应常规使用亚硝酸钠。
  • 亚硝酸钠未能改善入院生存率或出院生存率,不推荐用于该适应证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Therapeutic delivery of sodium nitrite during resuscitation improved survival in animal models of cardiac arrest, but efficacy has not been evaluated in clinical trials in humans. OBJECTIVE: To determine whether parenteral administration of sodium nitrite given by paramedics during resuscitation for out-of-hospital cardiac arrest improved survival to hospital admission. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled, phase 2 randomized clinical trial including 1502 adults in King County, Washington, with out-of-hospital cardiac arrest from ventricular fibrillation or nonventricular fibrillation. Patients underwent resuscitation by paramedics and were enrolled between February 8, 2018, and August 19, 2019; follow-up and data abstraction were completed by December 31, 2019. INTERVENTIONS: Eligible patients with out-of-hospital cardiac arrest were randomized (1:1:1) to receive 45 mg of sodium nitrite (n = 500), 60 mg of sodium nitrite (n = 498), or placebo (n = 499), which was given via bolus injection by the paramedics as soon as possible during active resuscitation. MAIN OUTCOMES AND MEASURES: The primary outcome was survival to hospital admission and was evaluated with 1-sided hypothesis testing. The secondary outcomes included out-of-hospital variables (rate of return of spontaneous circulation, rate of rearrest, and use of norepinephrine to support blood pressure) and in-hospital variables (survival to hospital discharge; neurological outcomes at hospital discharge; cumulative survival to 24 hours, 48 hours, and 72 hours; and number of days in the intensive care unit). RESULTS: Among 1502 patients with out-of-hospital cardiac arrest who were randomized (mean age, 64 years [SD, 17 years]; 34% were women), 99% completed the trial. Overall, 205 patients (41%) in the 45 mg of sodium nitrite group and 212 patients (43%) in the 60 mg of sodium nitrite group compared with 218 patients (44%) in the placebo group survived to hospital admission; the mean difference for the 45-mg dose vs placebo was -2.9% (1-sided 95% CI, -8.0% to ∞; P = .82) and the mean difference for the 60-mg dose vs placebo was -1.3% (1-sided 95% CI, -6.5% to ∞; P = .66). None of the 7 prespecified secondary outcomes were significantly different, including survival to hospital discharge for 66 patients (13.2%) in the 45 mg of sodium nitrite group and 72 patients (14.5%) in the 60 mg of sodium nitrite group compared with 74 patients (14.9%) in the placebo group; the mean difference for the 45-mg dose vs placebo was -1.7% (2-sided 95% CI, -6.0% to 2.6%; P = .44) and the mean difference for the 60-mg dose vs placebo was -0.4% (2-sided 95% CI, -4.9% to 4.0%; P = .85). CONCLUSIONS AND RELEVANCE: Among patients with out-of-hospital cardiac arrest, administration of sodium nitrite, compared with placebo, did not significantly improve survival to hospital admission. These findings do not support the use of sodium nitrite during resuscitation from out-of-hospital cardiac arrest. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03452917.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Kim F, Maynard C, Dezfulian C, et al. Effect of Out-of-Hospital Sodium Nitrite on Survival to Hospital Admission After Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2021. PMID: 33433575. doi:10.1001/jama.2020.24326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。